2025年中国生物细胞资源产业链洞察报告（一）：细胞存储技术

Investment Rating - The report does not explicitly provide an investment rating for the biological cell resource industry in China. Core Insights - The report aims to analyze the market development of the cell storage sector, focusing on technological advancements, policy environment, market size, and competitive landscape to provide decision-making references for related enterprises and investors [3]. Summary by Sections Overview of the Cell Storage Industry - The cell storage industry in China is evolving under supportive policies and regulatory frameworks, emphasizing product safety, quality control, and standardization [6]. - The aging population in China is increasing the demand for disease prevention, enhancing the value recognition of cell resource storage and regenerative medicine applications [6][26]. - Technological advancements have shifted cell storage from early low-temperature preservation to multi-mechanism collaborative strategies, addressing various challenges such as metabolic stability and oxidative stress [6]. Development Environment of the Cell Storage Industry - The continuous optimization of China's healthcare expenditure structure and the significant increase in government and social investment create a favorable environment for the biotechnology sector [21][25]. - The aging population and increasing life expectancy are driving the demand for preventive health investments, including cell storage [26][28]. Market Competition in the Cell Storage Industry - The Chinese cell storage market exhibits a multi-tiered competitive structure, with leading enterprises leveraging first-mover advantages and national layouts to drive automation and standardization [37]. - Local institutions benefit from regional policy support and local resources, forming strong regional influence [37]. - The third tier consists of numerous emerging and cross-industry companies with diverse business models, reflecting ongoing evolution and standardization within the industry [37].